Improvement in duration of erection following phosphodiesterase type 5 inhibitor therapy with vardenafil in men with erectile dysfunction: the ENDURANCE study

OBJECTIVE: The ENDURANCE study evaluated the efficacy of vardenafil, a phosphodiesterase type 5 (PDE5) inhibitor, in men with erectile dysfunction (ED), by measuring the duration of erection leading to successful intercourse using a stopwatch as the assessment instrument. METHODS: This was a randomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenberg, M T, Adams, P L, McBride, T A, Roberts, J N, McCallum, S W
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2009
Materias:
Urology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705823/
https://www.ncbi.nlm.nih.gov/pubmed/19125990
http://dx.doi.org/10.1111/j.1742-1241.2008.01947.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705823/
https://www.ncbi.nlm.nih.gov/pubmed/19125990
http://dx.doi.org/10.1111/j.1742-1241.2008.01947.x

Ejemplares similares